Andrew Rava, MPH

Associate Director, Epidemiology
Genesis Research Group

Poster(s):

• (354) Healthcare resource utilization following cariprazine initiation among medicare beneficiaries with bipolar I disorder
  Wednesday, October 29, 2025

• (355) Real-world switch rates of injectable migraine preventive therapies in patients with chronic migraine
  Wednesday, October 29, 2025